Ewing sarcoma‐family tumors that arise after treatment of primary childhood cancer
Authors:
- Sheri L. SpuntSSSheri L. Spunt
- JoAnn HarperJHJoAnn Harper
Open Access
Abstract
BACKGROUND: Unlike osteosarcoma, the Ewing sarcoma family of tumors (ESFT) has rarely been reported as secondary malignant neoplasms after treatment of childhood cancer. ESFT arising as a second cancer was reviewed and characterized at our childhood cancer center.METHODS: A retrospective review was undertaken of 11,183 patients age n = 3), leukemia (n = 1), retinoblastoma (n = 1), or Wilms tumor (n = 1). None of these patients had a family history suggestive of a familial cancer syndrome. The median time between diagnosis of primary cancer and diagnosis of ESFT was 5.9 years (range, 3.1‐18.3 years). ESFT occurred in typical anatomic locations: rib (n = 2), chest wall soft tissues (n = 2), pelvis (n = 1), and extremity (n = 1). One tumor arose at the margin of a previous radiotherapy field and 1 arose distant from previous radiotherapy fields; all other patients had not received radiotherapy. Three patients are alive at the time of this report, including 2 whose ESFT was diagnosed more than 8 years ago.CONCLUSIONS: ESFT occurs rarely after treatment of a primary cancer during childhood, and most cases do not appear to be related to radiation therapy. Long‐term survival can be achieved in some patients, and therefore secondary ESFT should be treated with curative intent. Cancer 2006. © 2006 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- STAT3 is activated in a subset of the Ewing sarcoma family of tumoursThe Journal of Pathology, 2006
- Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemiaPediatric Blood & Cancer, 2005
- Second malignancies after treatment for Ewing’s sarcoma: a report of the CESS-studiesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Radiotherapy, Alkylating Agents, and Risk of Bone Cancer After Childhood CancerJNCI: Journal of the National Cancer Institute, 1996
- Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma Therapy-associated secondary neoplasm or unrelated coincidence?Cancer Genetics and Cytogenetics, 1995
- Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin's disease: A case reportAnnals of Hematology, 1994
- A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERGNature Genetics, 1994
- Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumoursNature, 1992
- Bone sarcomas as second malignant neoplasms following childhood cancerCancer, 1991
- Bone Sarcomas Linked to Radiotherapy and Chemotherapy in ChildrenNew England Journal of Medicine, 1987